Search results for "Anticoagulation"
Fewer than 1% of ED patients with syncope found to have PE in retrospective analysis
The findings should discourage the adoption of routine protocols for excluding pulmonary embolism (PE) in all patients presenting to the ED with syncope, the authors said.
https://acphospitalist.acponline.org/weekly/archives/2018/02/07/3.htm
7 Feb 2018
November 16, 2022
ACP Hospitalist provides hospital-based physicians with news and information about the practice of hospital medicine.
https://acphospitalist.acponline.org/archives/2022/11/16/
Standardized rounds, antibiotics and acute kidney injury, and more
Summaries from ACP Hospitalist Weekly.
https://acphospitalist.acponline.org/archives/2017/06/in-the-news.htm
15 Jun 2017
Reports and recommendations on clot concerns with adenovirus COVID-19 vaccines
Based on reports of cerebral venous sinus thrombosis with the Johnson & Johnson (Janssen) COVID-19 vaccine, federal officials recommended a pause in its use, which will be reconsidered on April 23.
https://acphospitalist.acponline.org/weekly/archives/2021/04/21/1.htm
21 Apr 2021
Adding contraception to the conversation
A hospitalist explains a recent call for her peers to consider their patients' family planning needs.
https://acphospitalist.acponline.org/archives/2022/07/06/free/adding-contraception-to-the-conversation.htm
6 Jul 2022
Latest research, recommendations cover diabetes, clots, and remdesivir in COVID-19
Mortality was lower in diabetes patients given sitagliptin at admission for COVID-19, ACP practice points support remdesivir, acquired thrombophilia does not predict clots, cardiac arrest survival is low, and admissions for other conditions were still way down over the summer.
https://acphospitalist.acponline.org/weekly/archives/2020/10/07/1.htm
7 Oct 2020
Rivaroxaban after discharge may reduce thromboembolic risk in medically ill
An industry-funded trial that gave medical patients rivaroxaban for 45 days after hospital discharge found decreased risk for a composite end point of symptomatic venous thromboembolism, myocardial infarction, nonhemorrhagic stroke, and cardiovascular death compared to placebo.
https://acphospitalist.acponline.org/weekly/archives/2020/06/24/3.htm
24 Jun 2020
Major bleeding, mortality risks after VTE similar on DOACs or warfarin
The authors noted that the safety of DOAC treatment of VTE beyond 180 days remains uncertain and that 95% of DOAC users in the study were taking rivaroxaban, so further study of other agents is needed.
https://acphospitalist.acponline.org/weekly/archives/2017/10/25/3.htm
25 Oct 2017
COVID-19 research focuses on steroids, clots, hydroxychloroquine, zinc
Steroids' effects varied by C-reactive protein level, clots occurred despite prophylaxis, and hydroxychloroquine and zinc were ineffective for COVID-19, according to newly published studies.
https://acphospitalist.acponline.org/weekly/archives/2020/07/29/1.htm
29 Jul 2020
Therapeutic hypothermia, HAI network, and more
Summaries from ACP Hospitalist Weekly.
https://acphospitalist.acponline.org/archives/2020/05/recent-research.htm
15 May 2020